IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.783
EU - Europa 2.851
AS - Asia 2.504
SA - Sud America 445
Continente sconosciuto - Info sul continente non disponibili 262
AF - Africa 76
OC - Oceania 2
Totale 9.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.707
SG - Singapore 1.194
IT - Italia 576
UA - Ucraina 399
IE - Irlanda 394
CN - Cina 374
BR - Brasile 337
SE - Svezia 294
HK - Hong Kong 292
VN - Vietnam 283
RU - Federazione Russa 269
DE - Germania 220
FR - Francia 185
FI - Finlandia 140
RO - Romania 113
GB - Regno Unito 93
IN - India 75
KR - Corea 58
AR - Argentina 45
BD - Bangladesh 38
CA - Canada 37
CZ - Repubblica Ceca 33
TR - Turchia 33
BE - Belgio 25
IQ - Iraq 24
PL - Polonia 24
CH - Svizzera 18
CO - Colombia 18
EC - Ecuador 17
PK - Pakistan 17
MX - Messico 16
NL - Olanda 16
ZA - Sudafrica 16
CI - Costa d'Avorio 15
UZ - Uzbekistan 15
ID - Indonesia 13
JP - Giappone 13
ES - Italia 12
AT - Austria 11
GR - Grecia 11
PH - Filippine 11
MA - Marocco 9
VE - Venezuela 9
LB - Libano 8
SA - Arabia Saudita 8
PE - Perù 7
TN - Tunisia 7
IL - Israele 6
LT - Lituania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
PS - Palestinian Territory 5
ET - Etiopia 4
EU - Europa 4
PY - Paraguay 4
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
LC - Santa Lucia 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LR - Liberia 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
Totale 9.656
Salva come PNG Salva come JPEG
Città #
Singapore 881
Chandler 427
Dublin 394
Perugia 326
Hong Kong 288
San Jose 248
San Mateo 232
Jacksonville 193
Ashburn 173
Boardman 157
Dong Ket 135
Santa Clara 133
Bucharest 111
Beijing 105
Wilmington 98
Medford 94
Princeton 93
Moscow 91
Altamura 89
Redmond 89
Munich 82
Lauterbourg 80
Ann Arbor 77
Andover 70
Des Moines 70
Lawrence 68
Los Angeles 58
Seoul 57
Ho Chi Minh City 56
New York 54
Falls Church 45
The Dalles 35
Dearborn 34
São Paulo 32
Turku 32
Hanoi 30
Orem 30
Woodbridge 28
Chennai 26
Dallas 26
Pisa 26
Saint Petersburg 26
Brussels 25
Norwalk 22
Helsinki 21
Piscataway 21
Chicago 19
Council Bluffs 19
Boston 18
Brno 18
Frankfurt am Main 17
Warsaw 17
Fremont 16
Milan 16
Nuremberg 16
Abidjan 15
Brooklyn 15
San Paolo di Civitate 14
Olomouc 13
Poplar 13
Atlanta 12
Denver 12
Tokyo 12
Izmir 11
Phoenix 11
Shanghai 11
Baghdad 10
Guangzhou 10
Haiphong 10
London 10
Manchester 10
Montreal 10
San Francisco 10
Belo Horizonte 9
Johannesburg 9
Mumbai 9
San Diego 9
Seattle 9
Buffalo 7
Columbus 7
Fortaleza 7
Houston 7
Medellín 7
Nanjing 7
Paris 7
Ankara 6
Buenos Aires 6
Den Haag 6
Guayaquil 6
Hanover 6
Istanbul 6
Jinan 6
Joinville 6
Nagpur 6
Rio de Janeiro 6
Stockholm 6
Tashkent 6
Tianjin 6
Toronto 6
Wuhan 6
Totale 6.037
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 212
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 207
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 204
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 201
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 186
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 183
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 175
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 160
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 160
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 157
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 149
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 149
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 147
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 145
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 143
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 140
The TGF-β/IDO axis in infectious tolerance. 137
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 131
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 131
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 129
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 128
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 125
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 124
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 124
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 122
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 121
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 120
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 120
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 118
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 117
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 117
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 116
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 115
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 114
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 112
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 110
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 109
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 106
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 105
Modulation of tryptophan catabolism by regulatory T cells 104
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 101
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 100
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 99
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 98
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 98
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 98
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 98
T cell apoptosis by tryptophan catabolism 97
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 97
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 97
CTLA-4-Ig regulates tryptophan catabolism in vivo. 96
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 96
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 94
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 93
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 93
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 91
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 89
Immunomodulatory properties of ribavirin in the mouse. 88
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 88
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 88
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 87
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 87
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 86
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 85
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 85
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 85
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 84
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 83
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 81
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 81
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 80
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 79
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 78
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 78
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 76
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 75
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 74
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 73
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 71
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 67
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 62
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 61
Molecular and genomic aspects of xenogenizing-alkylating drugs. 61
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 60
Tryptophan catabolism in nonobese diabetic mice. 59
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 56
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 55
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 51
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 50
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 48
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 37
Totale 9.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.126 0 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/20251.340 23 113 98 72 160 62 47 88 231 85 208 153
2025/20263.171 189 240 161 421 365 315 535 229 327 275 78 36
2026/2027148 66 82 0 0 0 0 0 0 0 0 0 0
Totale 9.923